These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7986425)

  • 1. Persistent anaemia in HIV-infected individuals due to parvovirus B19 infection.
    Zuckerman MA; Williams I; Bremner J; Cohen B; Miller RF
    AIDS; 1994 Aug; 8(8):1191-2. PubMed ID: 7986425
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute parvovirus B19 infection during anti-retroviral therapy.
    Taguchi H; Takahashi T; Goto M; Nakamura T; Iwamoto A
    J Infect Chemother; 2001 Jun; 7(2):110-2. PubMed ID: 11455501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
    Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
    Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvovirus B19 infection in HIV-1 infected patients with anemia.
    Gyllensten K; Sönnerborg A; Jorup-Rönström C; Halvarsson M; Yun Z
    Infection; 1994; 22(5):356-8. PubMed ID: 7843816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus.
    Chernak E; Dubin G; Henry D; Naides SJ; Hodinka RL; MacGregor RR; Friedman HM
    Clin Infect Dis; 1995 Jan; 20(1):170-3. PubMed ID: 7727646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
    van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
    Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 DNA detection in treatment-naïve HIV anemic patients in Lagos, Nigeria: a case control study.
    Ashaka OS; Salu OB; James AB; Oyefolu AOB; Anjorin AA; Oke BO; Orenolu MR; Omilabu SA
    Afr Health Sci; 2020 Mar; 20(1):219-226. PubMed ID: 33402910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facial rash in a pregnant woman.
    Waugh S; Brown KE
    J Clin Virol; 2009 Oct; 46(2):105-6. PubMed ID: 19716763
    [No Abstract]   [Full Text] [Related]  

  • 9. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique.
    Török TJ; Wang QY; Gary GW; Yang CF; Finch TM; Anderson LJ
    Clin Infect Dis; 1992 Jan; 14(1):149-55. PubMed ID: 1571420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
    Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
    Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
    Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
    Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent erythema in patients with long-term parvovirus B19 infection.
    Musiani M; Manaresi E; Gallinella G; Cricca M; Zerbini M
    Clin Infect Dis; 2005 Jun; 40(12):e117-9. PubMed ID: 15909254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Virological diagnosis of an outbreak of fever and rashes caused by parvovirus B19, Cuba, 1995].
    Guzmán MG; Rosario D; Rodríguez ME; Alvarez M; Rodríguez R; Oropesa S; Laferté J; Resik S
    Rev Cubana Med Trop; 1997; 49(1):14-20. PubMed ID: 9685954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus B19 clearance from peripheral blood after acute infection.
    Musiani M; Zerbini M; Gentilomi G; Plazzi M; Gallinella G; Venturoli S
    J Infect Dis; 1995 Nov; 172(5):1360-3. PubMed ID: 7594678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human parvovirus B19 infection in patients with or without underlying diseases.
    Sim JY; Chang LY; Chen JM; Lee PI; Huang LM; Lu CY
    J Microbiol Immunol Infect; 2019 Aug; 52(4):534-541. PubMed ID: 31257106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of parvovirus B19 infection.
    Sevall JS; Ritenhous J; Peter JB
    J Clin Lab Anal; 1992; 6(4):171-5. PubMed ID: 1403335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa.
    Schoub BD; Blackburn NK; Johnson S; McAnerney JM
    S Afr Med J; 1993 Jul; 83(7):505-6. PubMed ID: 8211491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baboon-like syndrome induced by Parvovirus B19 in a child.
    Filippi F; Lombardo V; Chessa MA; Virdi A; Gurioli C; Neri I
    Int J Dermatol; 2020 May; 59(5):e157-e159. PubMed ID: 31957863
    [No Abstract]   [Full Text] [Related]  

  • 19. Parvovirus B19 infection--an emerging infectious disease?
    Rahav G
    Isr Med Assoc J; 2002 Oct; 4(10):810-1. PubMed ID: 12389346
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of polymerase chain reaction for detection of human parvovirus B19.
    Tabrizi SN; Chen S; Borg AJ; Garland SM
    J Infect Dis; 1994 Oct; 170(4):1047-8. PubMed ID: 7930708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.